Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases |
| |
Authors: | Ni Guo-Hua Chen Jin-Fang Chen Xiao-Ping Yang Tian-Lun |
| |
Affiliation: | Department of Cardiology, Xiang-Ya Hospital of Central South University, Changsha, PR China. |
| |
Abstract: | Epoxyeicosatrienoic acids (EETs) are cytochrome P450 (CYP450) products of arachidonic acid and EETs are endogenous lipid mediators synthesized by the vascular endothelium which perform important biological functions, including vasodilation, anti-inflammation, antimigratory, and cellular signaling regulations. However, EETs are rapidly degraded by soluble epoxide hydrolase (sEH) to the corresponding diols: dihydroxyeicosatrienoic acids (DHETs), which have little active in causing vasorelaxation. A number of studies have supported that the inhibition of sEH (sEHIs) had cardiovascular protective effects in hypertension, cardiac hypertrophy, atherosclerosis, ischemia-reperfusion injury, and ischemic stroke. Moreover, sEHIs could slow the progression of inflammation, protect end-organ damage and prevent ischemic events, also, attenuate endothelial dysfunction, suggesting that the pharmacological blockade of sEH might provide a broad and novel avenue for the treatment of many cardiovascular diseases. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|